(R)-(2,3-dimethoxyphenyl)(1-(2-(4-fluorophenyl)ethyl)piperidin-4-yl)methanol,
4-piperidinemethanol, alpha-(2,3-dimethoxyphenyl)-1-(2-(4-fluorophenyl)ethyl)-, (alpha-R)-,
alpha-(2,3-dimethoxyphenyl)-1-(2-(4-fluorophenylethyl))-4-piperidine methanol,
M100907,
MDL 100,907,
MDL 100105,
MDL 100907,
MDL-100,907,
MDL-100907,
MDL100105,
volinanserin,
Volinanserin,
139290-65-6,
MDL-100907,
Mdl 100907,
M100907,
UNII-EW71EE171J,
(R)-(2,3-Dimethoxyphenyl)(1-(4-fluorophenethyl)piperidin-4-yl)methanol,
MDL-100,907,
CHEMBL74355,
EW71EE171J,
MDL100907,
Mdl 100,907,
(R)-(+)-ALPHA-(2,3-DIMETHOXYPHENYL)-1-[2-(4-FLUORO-PHENYL)ETHYL]-4-PIPERIDINE METHANOL,
M-100907,
(R)-(2,3-Dimethoxy-phenyl)-{1-[2-(4-fluoro-phenyl)-ethyl]-piperidin-4-yl}-methanol,
(R)-(2,3-dimethoxyphenyl)-[1-[2-(4-fluorophenyl)ethyl]piperidin-4-yl]methanol,
Volinanserin [INN],
alpha-(2,3-Dimethoxyphenyl)-1-(2-(4-fluorophenylethyl))-4-piperidine methanol,
Serotonin 5-HT2 Receptor Antagonists,
MDL100.907,
AC1NSKC8,
DSSTox_CID_27363,
DSSTox_RID_82298,
DSSTox_GSID_47363,
GTPL185,
SCHEMBL675164,
MDL-100907(Volinanserin),
DTXSID6047363,
(2,3-Dimethoxy-phenyl)-{1-[2-(4-fluoro-phenyl)-ethyl]-piperidin-4-yl}-methanol,
4-Piperidinemethanol, alpha-(2,3-dimethoxyphenyl)-1-(2-(4-fluorophenyl)ethyl)-, (+)-,
HXTGXYRHXAGCFP-OAQYLSRUSA-N,
ZINC598040,
KS-000007QR,
Tox21_300244,
BDBM50095027,
MFCD00909060,
AKOS022180892,
API0000883,
PB23201,
MDL-100.907,
NCGC00247964-01,
NCGC00254173-01,
AJ-23647,
AK-59012,
AS-35103,
HY-14940,
CAS-139290-65-6,
CS-0003646,
FT-0675845,
Q-3721,
M100907, >=98% (HPLC),
MDL 100907, (R)-(+)-,
(R)-(1-(4-fluorophenethyl)piperidin-4-yl)(2,3-dimethoxyphenyl)methanol,
(R)-(+)-?-(2,3-Dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperinemethanol,
(R)-(+)-a-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-pipidinemethanol,
(R)-(2,3-Dimethoxyphenyl)-(1-(2-p-fluorophenylethyl)-piperidine-4-yl)-methanol,
(R)-alpha-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol,
4-Piperidinemethanol, alpha-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-, (alphaR)-,
(2,3-Dimethoxy-phenyl)-{1-[2-(4-fluoro-phenyl)-ethyl]-piperidin-4-yl}-methanol (M 100907),
(2,3-Dimethoxy-phenyl)-{1-[2-(4-fluoro-phenyl)-ethyl]-piperidin-4-yl}-methanol(MDL 100907),
D0HZ2E,
D0S6PV,
C22H28FNO3,
C22-H28-F-N-O3,
MDL100105,
CID5311271,
MDL 100105,
C079049,
- -ALPHA- -1-[2- ETHYL]-4-PIPERIDINEMETHANOL,
(R)-(2,3-dimethoxyphenyl)(1-(2-(4-fluorophenyl)ethyl)piperidin-4-yl)methanol,
4-PIPERIDINEMETHANOL, A-(2,3-DIMETHOXYPHENYL)-1-[2-(4-FLUOROPHENYL)ETHYL]-, (AR)-,
4-piperidinemethanol, alpha-(2,3-dimethoxyphenyl)-1-(2-(4-fluorophenyl)ethyl)-, (alpha-R)-,